The Food and Drug Administration has announced its agenda for a meeting that will examine the deadly infections that have occurred in women who took the abortion drug, RU-486. The Wall Stree Journal reports:
The meeting, to be held jointly with the Centers for Disease Control and Prevention and the National Institute of Allergy and Infectious Diseases at the CDC's Atlanta campus on Thursday, will focus on scientific questions about the origins, cause and need for future research about infections due to the bacterium Clostridium sordellii, as well as another type of pathogen that has no tie to the drug. Mifepristone, known by the brand name Mifeprex and sometimes called RU-486, is made by Danco Laboratories LLC and is given in combination with another drug, misoprostol, to cause an abortion in the early stages of pregnancy.
Panels of scientists are expected to discuss the infections, but possible regulatory actions won't be debated. An FDA official said the agency, which has added warning language to the drug's label, might consider further moves, but it first wants a better scientific grasp of the issues.
Disclaimer: The statements and articles listed here, and any opinions, are those of the writers alone, and neither are opinions of nor reflect the views of ProLifeBlogs. Aggregated content created by others is the sole responsibility of the writers and its accuracy and completeness are not endorsed or guaranteed. This goes for all those links, too: ProLifeBlogs has no control over the information you access via such links, does not endorse that information, cannot guarantee the accuracy of the information provided or any analysis based thereon, and shall not be responsible for it or for the consequences of your use of that information.
